# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Over $280 Million in Combined Cash and Securities and at least Three Years Operating Runway to Support Launch and Commercializa...
Silverback Therapeutics, Inc. (Nasdaq: SBTX) ("Silverback") today announced that the U.S.
Gainers
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares gained 93% to $10.32. Pagaya Technologies is expected to announce its...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Gainers
Silverback Therapeutics, Inc. (NASDAQ:SBTX) ("Silverback") and ARS Pharmaceuticals, Inc. ("ARS") today announce...